Larimar Therapeutics Inc (NASDAQ: LRMR) kicked off on Monday, up 4.44% from the previous trading day, before settling in for the closing price of $3.38. Over the past 52 weeks, LRMR has traded in a range of $1.61-$7.61.
Healthcare Sector giant saw their annual sales surged by 50.78% over the last five years. While this was happening, its average annual earnings per share was recorded -48.77%. With a float of $47.71 million, this company’s outstanding shares have now reached $85.59 million.
Larimar Therapeutics Inc (LRMR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Larimar Therapeutics Inc is 44.26%, while institutional ownership is 57.54%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.45 earnings per share (EPS), lower than consensus estimate (set at -0.32) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -48.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.92% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Take a look at Larimar Therapeutics Inc’s (LRMR) current performance indicators. Last quarter, stock had a quick ratio of 4.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.93, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.88 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Analysing the last 5-days average volume posted by the [Larimar Therapeutics Inc, LRMR], we can find that recorded value of 1.3 million was lower than the volume posted last year of 1.51 million. As of the previous 9 days, the stock’s Stochastic %D was 36.37%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 28.13%, which indicates a significant increase from 27.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was lower than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.09, while its 200-day Moving Average is $3.19. Now, the first resistance to watch is $3.66. This is followed by the second major resistance level at $3.80. The third major resistance level sits at $3.97. If the price goes on to break the first support level at $3.35, it is likely to go to the next support level at $3.18. Now, if the price goes above the second support level, the third support stands at $3.04.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
The company with the Market Capitalisation of 302.14 million has total of 82,778K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -80,600 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -47,710 K.
